Trial Site Detail
Drug: |
Pembrolizumab + Cyclophosphamide |
|||
|---|---|---|---|---|
Trial: |
Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial (PEMBROSARC) |
|||
| Conditions: | Sarcoma | |||
Trial Status: |
Active, not recruiting |
|||
Centre Oscar Lambret - Lille |
Principal Investigator: |
Nicolas Penel |
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Centre Oscar Lambret - Lille Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.